On Friday, Shares of Ctrip.com International Ltd. (NASDAQ:CTRP), gained 17.56% to $84.63, hitting its highest level.
Ctrip.com International, declared its investment in eLong, Inc. (LONG) through acquiring eLong shares from certain selling shareholders, counting Expedia, Inc. (EXPE), together with several other investors. Ctrip attained a 37.6% equity stake in eLong for a total purchase price of about $400 million.
In addition, Ctrip and Expedia have agreed to cooperate with each other to allow their respective customers to benefit from certain travel product offerings for specified geographic markets.
The transaction closed on May 22, 2015.
Ctrip.com International, Ltd., together with its auxiliaries, provides travel services for hotel accommodations, transportation ticketing services, packaged tours, and corporate travel administration in the People’s Republic of China. It also offers independent leisure travelers bundled packaged-tour products, counting group tours, semi-group tours, and private tours or packaged tours with various transportation arrangements, such as cruise, bus, or self-driving.
Shares of Xerox Corporation (NYSE:XRX), declined -0.61% to $11.44, during its last trading session.
At its annual meeting of shareholders, Ursula Burns, chairman and CEO of Xerox (XRX), highlighted the company’s solid financial position; the benefits of its diverse portfolio; and the steps Xerox is taking to drive long-term profitable growth.
Burns noted that Xerox delivered value for shareholders in 2014 by:
- Growing adjusted earnings per share by 3 percent to $1.07 and GAAP earnings per share by 1 percent to $0.90
- Posting $19.5 billion in full-year revenue
- Delivering $2.1 billion in operating cash flow
- Repurchasing $1.1 billion in Xerox shares and paying over $300 million in dividends
- Increasing the common stock dividend per share by 8.7 percent
- Announcing an agreement to sell its Information Technology Outsourcing (ITO) business to Atos for just over $1.0 billion preceding to closing adjustments, enabling the company to use the funds toward its 2015 capital allocation strategy, which comprises about $1 billion for repurchasing shares.
Xerox Corporation provides business process and document administration solutions worldwide. The company’s Services segment offers various business process outsourcing services, such as customer care, transaction processing, human resources, communication and marketing, and consulting and analytics services, in addition to finance, accounting, and procurement services.
At the end of Friday’s trade, Shares of The AES Corporation (NYSE:AES), lost -0.58% to $13.70.
Andrés Gluski, President and Chief Executive Officer of The AES Corporation, will address Bernstein’s 31st Annual Planned Decisions Conference on Friday, May 29, 2015 at 9:00 AM Eastern Time.
The AES Corporation operates as a diversified power generation and utility company. It owns and/or operates power plants to generate and sell power to customers, such as utilities, industrial users, and other intermediaries.
Finally, Mylan N.V. (NASDAQ:MYL), ended its last trade with -0.40% loss, and closed at $69.66.
Mylan, declared that it was asked by the Irish Takeover Panel to issue the following clarification and retraction in accordance with the Irish Takeover Rules, regarding its firm intention to make an offer to acquire the issued and to be issued shares of Perrigo (NYSE: PRGO; TASE). The clarification and retraction relates to certain forward-looking statements made by Mylan specifically during The Pendency Of The Offer Period concerning its long-stated target since 2012 of at least $6.00 in adjusted diluted earnings per share by 2018, in Mylan’s first quarter counting recently earnings press release of May 5, 2015.
Subsequent to the May 5 earnings release, Perrigo presented a complaint to the Irish Takeover Panel alleging that the reference to Mylan’s long-term target should be treated as a forward-looking profit forecast statement for purposes of the Rules, and therefore must comply with the terms of the Rules.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
